慢性肺源性心脏病合并右心衰竭的疗效观察.docVIP

慢性肺源性心脏病合并右心衰竭的疗效观察 　　doi：10.3969/j.issn.1007-614x.2014.16.12 　　摘 要 目的：探讨慢性肺源性心脏病合并右心衰竭采用卡托普利和安体舒通以及生脉治疗的临床效果。方法：收治慢性肺源性心脏病合并右心衰患者60例，按照随机数字表法分为试验组和对照组各30例。对照组采用强心、利尿等常规治疗；试验组在对照组治疗基础上加用卡托普利和安体舒通以及生脉治疗。结果：经过治疗后，试验组有效率96.7%（29/30）明显高于对照组83.3%（25/30），差异具有统计学意义（P0.05）。结论：在强心和利尿等治疗基础上，对慢性肺源性心脏病合并右心衰竭患者采用卡托普利、安体舒通以及生脉治疗，可有效地改善患者心功能等症状，同时缩短患者的心衰时间，提高治疗效果。 　　关键词 慢性肺源性心脏病 右心衰 卡托普利 安体舒通 生脉 　　Curative effect observation of chronic pulmonary heart disease complicated with right heart failure 　　Hou Jinxia 　　Internal Medicine，the First Branch of Coking Coal Group Central Hospital，Jiaozuo City，Henan 454000 　　Abstract Objective：To explore the clinical effect of chronic pulmonary heart disease complicated with right heart failure treated with captopril and spironolactone and Sheng Mai treatment.Methods：60 cases with chronic pulmonary heart disease complicated with right heart failure were selected.They were divided into the experimental group and the control group with 30 cases in each group according to random number table method.The control group were treated by cardiotonic，diuretic and other conventional treatment.The experimental group added captopril and spironolactone and Sheng Mai treatment on the basis of the control group.Results：After treatment，the effective rate of 96.7%（29/30） of the experimental group was significantly higher than that in control group of 83.3%（25/30）.The difference was statistically significant（P0.05）.Conclusion：On the basis of cardiotonic and diuretic treatment，the chronic pulmonary heart disease complicated with right heart failure patients were treated with captopril，spironolactone and Sheng Mai treatment，which can effectively improve heart function of patients，shorten the time of patients with heart failure，and improve the therapeutic effect. 　　Key words Chronic pulmonary heart disease；Right heart failure；Captopril；Spironolactone；Sheng Mai 　　慢性肺源性心脏病主要是因患者发生慢性阻塞性肺疾病（COPD）而导致，在COPD患者急性加重期，患者会发生右心衰等症状[1]。然而对于COPD，目前还没有较为理想的治疗药物。我院对此次收治的